AOTMiT: What will the Transparency Council address today?

Agenda:

1. Preparation of a position paper on the evaluation of the drug Ibrance (palbociclibum) under drug program B.9.FM "Treatment of patients with breast cancer (ICD-10: C50)".
2. Preparation of opinions on recommended medical technologies and activities carried out within the framework of health policy programs, as well as the conditions for implementation of these programs in the field:
   
   • Cardiovascular disease prevention,
   • hypertension,
   • hypercholesterolemia.

3 Prepare a position paper to examine the appropriateness of issuing reimbursement approvals for the medicinal product Rezurock (belumosudil) for the indication: treatment of adult and pediatric patients aged 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic treatment

4 Prepare an opinion on the draft health policy program of the local government unit "Rehabilitation of treatment for residents of Lodz province aged 60+ for 2026-2028".

5 Prepare an opinion on the draft health policy program of the local government unit "Program of dissemination of first aid skills for students of class VII of elementary schools from the municipality of Długołęka for 2026-2027".

Source: AOTMiT